CDMRP Tuberous Sclerosis Complex Research Program: Idea Development Award

The Idea Development Award promotes new ideas that are in the early stages of development and have the potential to yield high-impact findings and new avenues of investigation. Preliminary data should be presented. The program offers separate tracks for established and new investigators 

Focus Areas:

• Understanding, preventing, and treating the features of TSC-Associated Neuropsychiatric Disorders (TAND) and reducing their impact, including pharmacological, behavioral, and surgical interventions
• Strategies for eradicating tumors associated with TSC and TSC-associated lymphangioleiomyomatosis (LAM), including gaining a deeper mechanistic understanding for tumor microenvironment, TSC signaling, and mTOR interdependent pathways
• Preventing epilepsy, improving treatment, and mitigating neurodevelopmental and adverse outcomes associated with TSC-related seizures
• Developing, assessing, and testing emerging technologies including imaging and molecular therapeutic strategies, such as gene therapy, to improve outcomes in TSC

It is expected that 3 awards will be granted.

Funding: $500,000 total.
Duration: 3 years

Research Authority due date:  1.6.23

Pre application (required) due date: 8.6.23

Full application due date: 7.7.23